Key Points

HIV Infections and AIDS

• HIV Surveillance

  • Participation in LaboVIH: Comprehensive In 2023, laboratory participation in the LaboVIH survey remains comprehensive, as it was in 2022, with all laboratories across all three islands participating in the survey.

  • Mandatory reporting (MR): close to comprehensiveThe comprehensiveness of mandatory reporting in 2023 has also increased significantly compared to 2022, with a rate of 95%. These figures are higher than those observed in mainland France and than those observed in previous years in the region.

• HIV testing: on the rise

The estimated testing rate has risen to 220 per 1,000 inhabitants in Guadeloupe, Saint Martin, and Saint Barthélemy, making it the highest rate in France after French Guiana (260 per 1,000 inhabitants). However, since 2020, the proportion of late and advanced-stage diagnoses remains significant.

• HIV diagnosis (DO): stable

The number of new HIV diagnoses, adjusted for underreporting, missing data, and reporting delays in Guadeloupe, Saint Martin, and Saint Barthélemy was 85 in 2023. Over the past 10 years, the number of new diagnoses has remained stable.

• AIDS diagnosis (DO): stability

In Guadeloupe, Saint Martin, and Saint Barthélemy, the number of AIDS diagnoses is stable (compared to 2022) and significantly higher than during the 2014–2021 period.

Chlamydia trachomatis (Ct) infection

• In Guadeloupe, the Ct infection screening rate is 87.9 per 1,000 inhabitants, higher than the rate in mainland France excluding the Île-de-France region (39.8 per 1,000 inhabitants). The diagnosis rate for Ct infection is 137.7 per 100,000 inhabitants, higher than the rate in mainland France excluding Île-de-France (IdF) = (70.9 per 100,000 inhabitants).

Gonococcal infection

• In Guadeloupe, the screening rate for gonococcal infection is 90.7 per 1,000 inhabitants, higher than the rate in mainland France excluding Île-de-France (44.7 per 1,000 inhabitants). The diagnosis rate for gonococcal infection is 54.9 per 100,000 inhabitants, higher than the rate in mainland France excluding IdF (24.3 per 100,000 inhabitants).

Syphilis

• In Guadeloupe, the syphilis screening rate is 115.7 per 1,000 inhabitants, higher than the rate in mainland France excluding the Île-de-France region (43.1 per 1,000 inhabitants). The syphilis diagnosis rate is 12.6 per 100,000 inhabitants, higher than the rate in mainland France excluding the Île-de-France region (6.0 per 100,000 inhabitants).

Prevention

• “Mon test IST” has supplemented and replaced “VIHTest” since September 2024. In fact, the screening includes, in addition to HIV, the following infections: Chlamydia trachomatis, gonorrhea, syphilis, and hepatitis B (depending on vaccination status). These screenings are performed at no cost regardless of age for HIV and subject to being 26 years of age for other STIs.

• More information at ameli.fr